Dare Bioscience Inc (DARE) — Top EPS Revision Performer
As of 2026-05-05, Dare Bioscience Inc (DARE) has a next-year EPS growth estimate of 51.24%. Featured in 2 EPS revision reports, most recently on 2026-04-20. Sector: Healthcare.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 51.24%
- EPS growth this year
- -0.83%
- EPS next quarter (est)
- $-0.30
- Last price
- $3.27
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-05 | 51.24% | -0.83% | $-0.30 | $3.27 |
| 2026-05-04 | 51.24% | -0.83% | $-0.30 | $3.11 |
| 2026-05-03 | 51.24% | -0.83% | $-0.30 | $2.34 |
| 2026-04-30 | 51.24% | -0.83% | $-0.30 | $2.28 |
| 2026-04-29 | 51.24% | -0.83% | $-0.30 | $2.10 |
| 2026-04-28 | 51.24% | -0.83% | $-0.30 | $2.19 |
| 2026-04-27 | 51.24% | -0.83% | $-0.30 | $2.24 |
| 2026-04-26 | 51.24% | -0.83% | $-0.30 | $2.11 |
| 2026-04-24 | 51.24% | -0.83% | $-0.30 | $2.11 |
| 2026-04-23 | 51.24% | -0.83% | $-0.30 | $2.12 |
| 2026-04-22 | 51.24% | -0.83% | $-0.30 | $2.27 |
| 2026-04-21 | 51.24% | -0.83% | $-0.30 | $2.36 |
| 2026-04-20 | 51.24% | -0.83% | $-0.30 | $2.87 |
| 2026-04-19 | 51.24% | -0.83% | $-0.30 | $2.95 |
| 2026-04-16 | 51.24% | -0.83% | $-0.30 | $2.72 |
| 2026-04-15 | 51.24% | -0.83% | $-0.30 | $1.79 |
| 2026-04-14 | 51.24% | -0.83% | $-0.30 | $1.75 |
| 2026-04-13 | 51.24% | -0.83% | $-0.30 | $1.78 |
| 2026-04-12 | 51.24% | -0.83% | $-0.30 | $1.83 |
| 2026-04-10 | 51.24% | -0.83% | $-0.30 | $1.85 |
| 2026-03-27 | 495.65% | N/A | N/A | $1.55 |
| 2026-03-26 | 86.23% | N/A | N/A | $1.51 |
| 2026-03-26 | 86.23% | N/A | N/A | $1.51 |
| 2026-03-26 | 86.23% | N/A | N/A | $1.51 |
| 2026-03-25 | 86.23% | N/A | N/A | $1.40 |
| 2026-03-25 | 86.23% | N/A | N/A | $1.40 |
| 2026-03-25 | 86.23% | N/A | N/A | $1.40 |
| 2026-03-24 | 86.23% | N/A | N/A | $1.36 |
| 2026-03-24 | 86.23% | N/A | N/A | $1.36 |
| 2026-03-24 | 86.23% | N/A | N/A | $1.36 |
Reports Featuring DARE
Recent News
EPS revision data sourced from analyst consensus estimates, refreshed daily. Dare Bioscience Inc (DARE) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports